Embracing Challenges And Executing A Successful IPO

By John Jacobs

As I began my journey as CEO of Harmony Biosciences in 2018, I had no way of knowing that just two short years into my tenure a global pandemic would reshape our corporate journey and the world as we know it. In this unexpected challenge, I saw Harmony’s purpose more clearly than ever before: to improve the lives of people living with rare neurological diseases — a calling I know that I share with many others in the life sciences industry.